On Wednesday, December 12, the Bundeskartellamt presented the results of its sector inquiry into online comparison websites. The inquiry into a large number of comparison websites from the areas of travel, energy, insurance, telecommunications, and financial services has in some areas confirmed the suspicions of consumer rights violations. The companies concerned will now have the possibility to comment on the consultation paper, which was published Wednesday.
Andreas Mundt, President of the Bundeskartellamt stated: “Online comparison websites are an important tool, provided that they deliver objective and truthful results. A large part of the comparative information is correct and reliable. However, our inquiry has also shown that consumers’ rights could be violated in a number of cases. Consumers are often not informed about the details of the ranking criteria for their search results and the comparison websites’ recommendations, which can be misleading. For example, sometimes important insurers are not included in the comparison. Hotels can buy ranking positions on hotel booking platforms. And in some cases, a comparison website covers less than 50% of the offers available on the market. In short: Consumers cannot always rely on comparison websites to really find the best offer for their requirements.”
The consultation paper presented Wednesday details the outcome of the Bundeskartellamt’s investigations and contains an initial legal assessment. The market players concerned and other interested parties can comment on the paper until February 4, 2019. After assessing the comments the Bundeskartellamt is going to publish a conclusive report on its sector inquiry on comparison websites in 2019.
Full Content: Bundeskartellamt
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas